BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/10/2022 1:14:37 PM | Browse: 566 | Download: 1283
 |
Received |
|
2022-03-20 01:14 |
|
Peer-Review Started |
|
2022-03-20 01:15 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-17 03:17 |
|
Revised |
|
2022-04-26 03:41 |
|
Second Decision |
|
2022-07-01 03:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-07-06 04:23 |
|
Articles in Press |
|
2022-07-06 04:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-26 00:28 |
|
Publish the Manuscript Online |
|
2022-08-10 13:14 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chun-Ye Zhang, Shuai Liu and Ming Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ming Yang, DVM, PhD, Postdoctoral Fellow, Department of Surgery, University of Missouri, Roy Blunt NextGen Precision Health Building, Room 2203 1030 Hitt Street, Columbia, MO 65211, United States. yangmin@health.missouri.edu |
| Key Words |
COVID-19; SARS-CoV-2; Gut microbiota; Pancreatic cancer; Interleukin-6; Interleukin-8; Interleukin-10; Monoclonal antibodies; Modulatory treatment |
| Core Tip |
Pancreatic cancer (PC) is a leading cause of cancer-associated death worldwide. Currently, the pathogenesis of this disease is complicated without efficient therapy. Coronavirus disease 2019 (COVID-19) disease exacerbates the challenge of PC patients. The gut microbiome serves as a critical connector between viral infection and PC through the regulation of host systemic immune response. Therefore, by targeting the lung-gut-pancreases axis, we can modulate both cytokine storm and inflammation in patients with PC and COVID-19 infection. |
| Publish Date |
2022-08-10 13:14 |
| Citation |
Zhang CY, Liu S, Yang M. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World J Gastrointest Oncol 2022; 14(8): 1456-1468 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i8/1456.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i8.1456 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
